Sage Therapeutic Com (SAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 127,766 | 8,066 | 2,802 | N/A | N/A |
| TOTAL | $128,822 | $8,407 | $2,826 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 163 | 86 | 130 | N/A | N/A |
| Other Non-Current Assets | 680 | 39 | 39 | 0 | 0 |
| TOTAL | $843 | $125 | $169 | $N/A | $N/A |
| Total Assets | $129,665 | $8,532 | $2,995 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,429 | 1,988 | 1,314 | 0 | 0 |
| Accrued Expenses | 4,687 | 327 | 105 | N/A | N/A |
| TOTAL | $7,757 | $2,315 | $1,419 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 23 | 37,753 | 14,970 | 0 | 0 |
| TOTAL | $23 | $37,753 | $14,970 | $N/A | $N/A |
| Total Liabilities | $7,780 | $40,068 | $16,389 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,809 | N/A | N/A | N/A | N/A |
| Common Shares | 3 | 0 | N/A | N/A | N/A |
| Retained earnings | -66,845 | -31,675 | -13,394 | N/A | N/A |
| TOTAL | $121,885 | $-31,536 | $-13,394 | $N/A | $N/A |
| Total Liabilities And Equity | $129,665 | $8,532 | $2,995 | $0 | $0 |